Forget Congress — the real medtech question for 2027 is whether hospital customers can still afford capital equipment ...

Edwards Lifesciences raised its 2026 guidance for the third time this year, citing strong TAVR growth, new clinical data, and ...

The softer sales, along with reimbursement pressure in wound care, caused the London-based company to miss Wall Street ...

Understanding the realities patients face when using devices outside the hospital requires, well, getting out of the hospital ...

Examine how to architect intensive real-time control, high-resolution vision, AI inference, visualization, and data capture ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Guardant Health's Shield blood test wins the 2026 Prix Galien USA Award for Best Medical Technology, recognizing its impact ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

Draeger, BD, Edwards, Philips, Cardinal Health, Medline, and Nova Biomedical issued major recalls in October 2026 after ...

Democrats' new House and Senate majority could reshape drug pricing, ACA subsidies, and healthcare oversight heading into ...

Cochlear completes pivotal trial enrollment for its fully implantable hearing device. CTO shares insights on design, safety, ...

Few medtech firms use FDA's PCCP pathway because most lack the MLOps infrastructure needed to safely iterate AI models ...